Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosus

Affiliations

• ¹ Department of Internal Medicine and Clinical Immunology, Bordeaux University Hospital (Groupe Hospitalier Saint-André), Bordeaux, France; UMR/CNRS 5164, ImmunoConcEpT, CNRS, University of Bordeaux, Bordeaux, France.
• ² Laboratory of Immunology and Immunogenetic, Bordeaux University Hospital (Groupe Hospitalier Pellegrin), Place Amélie Raba Léon, Bordeaux, France.
• ³ Rheumatology department, FHU ACRONIM, Reference Center of rare auto-immune systemic diseases, Bordeaux University Hospital, Bordeaux, France.
• ⁴ UMR/CNRS 5164, ImmunoConcEpT, CNRS, University of Bordeaux, Bordeaux, France; Department of Internal Medicine and Infectious Diseases, CHU Bordeaux (Groupe Hospitalier Haut Leveque), Pessac, France.
• ⁵ UMR/CNRS 5164, ImmunoConcEpT, CNRS, University of Bordeaux, Bordeaux, France; Rheumatology department, FHU ACRONIM, Reference Center of rare auto-immune systemic diseases, Bordeaux University Hospital, Bordeaux, France.
• ⁶ UMR/CNRS 5164, ImmunoConcEpT, CNRS, University of Bordeaux, Bordeaux, France; Laboratory of Immunology and Immunogenetic, Bordeaux University Hospital (Groupe Hospitalier Pellegrin), Place Amélie Raba Léon, Bordeaux, France. Electronic address: patrick.blanco@chu-bordeaux.fr.